Inhaled Drug's heart effects scrutinized in small safety trial
NCT ID NCT00874237
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested whether a single inhaled dose of Staccato Loxapine affects the heart's electrical activity in 48 healthy adults. Participants received the drug, a placebo, and a control drug in random order, and their heart rhythms were measured. The goal was to check for heart-related side effects, not to treat any disease. The study found no major heart risks at the tested dose.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THOROUGH QT/QTC STUDY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Covance Clinical Research Unit Inc.
Evansville, Indiana, 47710, United States